Literature DB >> 9396952

HIV seroprevalence among suicide victims in New York City, 1991-1993.

P M Marzuk1, K Tardiff, A C Leon, C S Hirsch, N Hartwell, L Portera, M I Iqbal.   

Abstract

OBJECTIVE: The authors sought to determine the HIV seroprevalence among suicide victims in New York City.
METHOD: All suicides of city residents from 1991 through 1993 were studied. The crude proportion of all suicide victims who were HIV positive and the proportion adjusted to the age, gender, and racial/ethnic characteristics of the New York City population were determined. The demographically adjusted proportion was then contrasted with HIV seroprevalence estimates for the New York City general population. HIV-seropositive suicide victims were assessed for pathological findings suggestive of HIV-related illnesses.
RESULTS: The crude proportion of all suicide victims who were HIV seropositive was 0.088, and the demographically adjusted proportion was 0.049. Over 90% of all HIV-positive suicide victims were aged 25 to 54 years, and almost 90% were men. Among black and Hispanic men aged 35 to 54 years who committed suicide, the proportion who were HIV seropositive was 0.252--the highest seropositive rate of any demographic group. More than two-thirds of HIV-seropositive suicide victims had no HIV-related pathology or AIDS-indicator conditions at autopsy.
CONCLUSIONS: The demographically adjusted proportion of suicide victims who were HIV positive (approximately 0.038 to 0.059), contrasted with the HIV seroprevalence estimates for the New York City general population (approximately 0.014 to 0.032), the absence of HIV-related pathology among suicide victims, and the likelihood that many HIV-positive individuals had other risk factors for suicide, such as substance abuse, suggests that a positive HIV serostatus is associated, at most, with a modest elevation in suicide risk.

Entities:  

Mesh:

Year:  1997        PMID: 9396952     DOI: 10.1176/ajp.154.12.1720

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  6 in total

1.  Suicide mortality among people accessing highly active antiretroviral therapy for HIV/AIDS in British Columbia: a retrospective analysis.

Authors:  Jasmine Gurm; Hasina Samji; Adriana Nophal; Erin Ding; Verena Strehlau; Julia Zhu; Julio S G Montaner; Robert S Hogg; Silvia Guillemi
Journal:  CMAJ Open       Date:  2015-04-02

2.  Isoniazid overdose : a case series, literature review and survey of antidote availability.

Authors:  Graeme Maw; Peter Aitken
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

3.  Rates and risk factors for suicidal ideation, suicide attempts and suicide deaths in persons with HIV: a systematic review and meta-analysis.

Authors:  Matt Pelton; Matt Ciarletta; Holly Wisnousky; Nicholas Lazzara; Monica Manglani; Djibril M Ba; Vernon M Chinchillli; Ping Du; Anna E Ssentongo; Paddy Ssentongo
Journal:  Gen Psychiatr       Date:  2021-04-09

4.  Age, gender and suicidal ideation following voluntary HIV counseling and testing.

Authors:  Lourens Schlebusch; Romona Devi Govender
Journal:  Int J Environ Res Public Health       Date:  2012-02-10       Impact factor: 3.390

5.  The impact of chronic illness in suicidality: a qualitative exploration.

Authors:  Eleni Karasouli; Gary Latchford; David Owens
Journal:  Health Psychol Behav Med       Date:  2014-08-20

6.  Human Immunodeficiency Virus Infection Newly Diagnosed at Autopsy in New York City, 2008-2012.

Authors:  Chitra Ramaswamy; Tanya M Ellman; Julie Myers; Ann Madsen; Kent Sepkowitz; Colin Shepard
Journal:  Open Forum Infect Dis       Date:  2015-09-30       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.